Objective: This study aimed to explore the hepatotoxicity induced by silver nanoparticles (AgNPs) and to assess the hepatoprotective effects of α-lipoic acid (LA) against this toxicity. Methods: Thirty adult male rats were enrolled into 3 equal groups; Control, AgNPs (50 mg/kg/i.P) and LA (100 mg/kg/orally) +AgNPs. After 30 days, blood and liver tissues were collected for further studies. Results: AgNPs exposure enhanced lipid peroxidation(+281.7%) along with declines in glutathione (−58.3%) Level in hepatic tissues. The apparent hepatic oxidative damage was associated with obvious hepatic dysfunction that was ascertained by hepatopathological lesions.As, following AgNPs exposure, hepatic silver content and serum ALT, AST and ALP activities were increased, moreover allows calcium influx and induces intracellular calcium overload. Hepatic tissues treated with AgNPs showed down-regulation of all the genes considered (PGC-1α, Tfam and Nrf2).LA improved the serious effects of AgNPs on the liver tissues through its antioxidant andmetal chelator efficacy. Conclusion: Silver nanoparticles (AgNPs) can induce hepatotoxicity along with oxidative stress, substantial decrease in cell viability with concomitant increases in DNA damage. Oral treatment with LA effectively counteracted the adverse effects of AgNPs.
Introduction:
Silver nanoparticles (AgNPs) have been broadly used in various commercial products including wound dressings, drugs, cosmetics, bedding, water purification, washing machines, deodorants, humidifierstextiles, electronic appliances and biomedical products due to their strong antibacterial activity [1]. AgNPs can enter the body through different routes as inhalation, injection, ingestion, and dermal contact, resulting in a dosedependent increase of silver concentration in various organs [2]. Moreover, AgNPs have a toxic effect in their persistence. So, the concerns have been higher on the potential risk of using nanoparticles in medical applications [3]. Most AgNPswere found to accumulate in the liver, a major organ of detoxification. Their excessive accumulation in the liver caused various adverse effects including pathological changes in liver morphology, inflammatory cell infiltration, bile-duct hyperplasia, apoptosis and necrosis . Mitochondria appear to be the sensitive target for AgNPs which accumulate outside the mitochondria of the cell, cause direct mitochondrial damage, and disturb the function of the respiratory chain, resulting in ROS generation and oxidative stress [8] . PGC-1αconsidered as the "master regulator' of mitochondrial biogenesis, which improves the expression of nuclear genes encoding mitochondrial proteins [9], also distributed inside mitochondria where it forms a multiprotein complex with mitochondrial transcribtion factor A(mTFA) on mtDNA [10]. PGC-1α is the "master regulator' of mitochondrial biogenesis, which improves the expression of nuclear genes encoding mitochondrial proteins [9] , also forms a multiprotein complex with mitochondrial transcription factor A (mTFA) on mtDNA [10]. mtTFA is a nuclear-encoded factor that promotes mtDNA transcription and expression [11], increases mtDNA copy number [12], protects and repairs damaged mtDNA and restores mitochondrial function [13]. α-lipoic acid (LA) also known as thioctic acid is an organosulfur compound derived from octanoic acid [14] . LA is synthesized in the hepatic tissue and other tissues to a sufficient extent, for its role as an enzyme cofactor in intermediary metabolism. Moreover This study aimed to explore the hepatotoxicity induced by silver nanoparticles (AgNPs) and to assess the hepatoprotective effects of α-lipoic acid (LA) against this toxicity.
Materials and Methods: Chemicals and Reagents
AgNPs powder was purchased from Sigma-Aldrich (St. Louis, MO,USA). The particles were suspended in deionized water by vigorousvortexing and sonication prior to use to ensure the prevention of particle aggregation. LA was obtained from (NATROL, Inc. Chatsworth, USA). HNO3and HCl were purchased from (Sigma-Aldrich). Kits for ALT, AST, ALP, Total protein, Albumin, Triacylglycerol,Total cholesterol,HDLc, total and direct bilirubin were purchased from vitro,Science Co., Egypt.
Nanoparticles characterization
The morphology and the particle size of AgNPs were examined bytransmission electron microscope (TEM) [21]. Briefly, AgNPs powder was suspended in deionized water (2 mg/mL). A drop of this solution was deposited on an amorphous carbon coated copper grid, which left to evaporate at room temperature forming a monolayer. Analysis of the particle size diameter of the prepared AgNPs was estimated using the software program image J over several shots of TEM images.
Experimental Design
Thirty male Wistar Albino rats weighing 150±20g were purchasedfrom Animal Breeding Unit, Medical Research Institute, Alexandria University. The animals were kept in metal cages under environmental controlled conditions with optimum temperature, humidity, and dark/light cycle and free access to rat chow and drinking water. The international ethical guidelines for the care and use of laboratory animals were performed to handle the animals and the experimental procedures were approved by the Experimental Animal Use and Ethics Committee at the Faculty of Veterinary Medicine, Alexandria University, Egypt.The rats were randomly assigned to three groups (10 rats each); control, AgNPsintoxicated group intraperitoneally injected with AgNPs 50 mg/kgb.w., 3 times a week [22], LA+AgNPs group intoxicated with AgNPs and orally gavaged with 100 mg LA/kg b.w. [23]. All treatments were continued for 30 consecutive days. Twenty-four hours after the last doses, the rats were anesthetized using ketamine/xylazine (7.5-10 mg/kg, 1 mg/kg i.p). The blood was collected from the innercanthus, and the sera were separated for estimation of alanine aminotransferase (ALT), aspartate aminotransferase (AST), akaline phosphatase (ALP), total protein, albumin, total and direct bilirubin, triglycerides (TG), total cholesterol and high density lipoprotein cholesterol (HDL-c). The rats were then euthanized and the liver were immediately dissected, rinsed with chilled normal saline 0.9% and divided into three parts; first one was used for gene expression of Nrf2, PGC-1α and mTFA and the second part was used for estimation of Ag, trace elements and finally third part was used for oxidative indices.
Estimation of silver, iron, copper, Ca and Zn contents
About 1 g of liver tissue was ashed at 600 °C, the ash was digested with acid mixture solution (HNO3 and HCl)then all samples were filtered, and diluted. Liver content of Ag + , Fe 2+ , Ca 2+ ,Cu 2+ and Zn 2+ were quantitatively measured by Inductively Coupled Plasma Mass Spectrometry (ICP-MS, Optima 5300DV, Analytik Jena, CO, USA) [24] .
Lipid peroxidation and antioxidant profile
The liver (about 1 g) was homogenized using Teflon and pestle homogenizer in ice-cold 0.1M phosphate buffer saline pH 7.4. The supernatant was separated after centrifuging the crudehomogenate at 14,000 rpm for 10 min at 4 °C. Lipid peroxide wasmeasured after the reaction with thiobarbituric acid and expressed as nmol malondialdehyde (MDA) per gram tissue [25]. Griffith method [26] was used to measure the total glutathione and GSSG content.
RNA extraction and qRT-PCR
About 100 mg hepatic tissues were rinsed in sterilized phosphatebuffer saline and homogenized in liquid nitrogen using Teflon andpestle homogenizer then the homogenates were stored at −80 °C till RNA isolation. Total RNA was isolated using the RNeasy Mini Kit(Qiagen GmbH, Germany) according to the manufacturer instructions. cDNA was synthesized from the purified RNA using QuantiTect Reverse Transcription Kit (Qiagen). The qRT-PCR for the target genes were performed using QuantiTect SYBR Green PCR Master Mix (Qiagen Rotor-Gene Q). The primer sequences of all targetand reference genes and the PCR conditions were recorded in Table  1 . The fold change of mRNA expression was calculated after recording the Ct values for reference and target genes using the 2−ΔΔCt method.
Statistical analyses
The distribution of each variable was assessed with the Shapiro-Wilk test, and variance homogeneity among groups was checked with the Levene"s test. When parametric assumptions were valid, we used univariate analysis of variance (ANOVA) with Tukey"s test as a post-hoc. Otherwise, the nonparametric alternatives (Kruskal-Wallis test and Dunn"s post-hoc test) were performed. A probability value 0.05 or less was considered statistically significant.
All analyses were performed using the SPSS statistical software package (version 22, IBM Corp., Armonk, NY, USA).
Results and disscussion:
The results in table (2), (3), and figure (2) indicated significant higher liver content of silver, calcium, GSSG and MDA levels and also, it induces a significant reduction in GSH level, significant down regulation of Nrf2, PGC-1α and mTFA in rats treated with AgNPs compared to control rats. Interestingly, the co-supplementation of AgNPs treated rats with LA resulted in significant reduction in the liver content of silver, calcium, GSSG and MDA levels. Moreover, LA results in significant up regulation of Nrf2, PGC-1α and mTFA and also, significant increment in GSH level compared to AgNPs treated rats. Previous studies showed that intraperitoneal injection achieved the highest hepatic tissue (the major organ of detoxification [27]) deposition of AgNPs as compared to other routes of administration [28] . Herein, intraperitoneal injection of AgNPs leads to silver hepatic accomulation initiating hepatotoxicity in rats. It has been generally thought that hepatic nanosilver toxicity is mainly due to the production of ROS in the liver [41] approved that LA supplementation significantly reduced MDA. Attractively, we can concluded that LA highly reduced the silver content in the liver indicating its clearance ability via incorporation of sulfhydryl group, upregulated of Nrf2 that inhibit ROS generation resulted in upregulation of PGC-1α that up regulated mTFA which are responsible for mitochondrial biogenesis, mtDNA trancribtion and replication and also, increases GSH synthesis leading to reduced the Ca 2+ content in the liver indicating its protective effect on NMDA receptors. Finally, from previous data we can report that LA protect hepatic cell from damage. Data in table (4) showed that LA resulted in significant correction in the activities of ALT, AST, and ALP compared to AgNPs treated rats. While, results in table (5) cleared that there was no significant difference in serum total protein, Albumin Globulin, total and direct bilirubin in different groups. However, AgNPs treated group showed decrease in both levels of total protein and albumin while, direct bilirubin concentration was increased but those alterations were not significant as compared to other groups. The previous oxidative stress induced by AgNPs administration consenquently lead to liver damage as ALT, AST and ALP activities were increased , in addition our histopathological findings confirmed this damage as there was focal hepatic necrosis and degeneration of biliary epithelium of bile duct. The variations to the levels of hepatic enzymes considered as adaptive mechanisms by the animals trying to equipoise stress enforced by exposure to the AgNPs [42].This result was harmonized with [43] who reported that the dosage of 50mg/kg produced significant increaseof AST, ALT and ALP .The potential of AgNPsfor modulation the enzyme activity wasdue to their affinity for thiol groups. Thiol groups in the enzymes made them attractive to the AgNPs leading to formation of complexes. Similarly, [3] showed that intravenous administration of AgNP at 40 mg/kg in Wistar rats exhibited significant increase in the levels of ALT, AST, ALP, GGT and total bilirubin [22]. [44] showed that the rate of total bilirubin had no significant change. On the other hand, coadministration of LA inhibited the development of liver injury, as indicated by reductions of liver function enzymes [45] and this came in harmony with our histopathological findings that mentioned improvement of hepatic lesion as compared with nanosilver group.
Results in table (6) cleared that in compared to control values, AgNPs induced a significant reduction in HDL-c level alongside with a significant increment in Total cholesterol, LDL-c and TG levels. Compared to AgNPs group, coadministration of LA showed lipid lowering activity as there was significant rise in HDL-c level along with the reduction of Total cholesterol, TG and LDL-c. Silver nanoparticles administration had a negative effect on serum lipid profile. Similarly, [46] showed that administration of an aqueous solution of silver nanoparticles to chickens causing an increase in total cholesterol, TG and LDL-c due to hepatocellular damage. On the other hand, co-treatment with LA elevated serum HDL-c level and decreased levels of total cholesterol, LDL-c, TG and VLDL-c. This result come in agreement with [47] who showed that LA has the ability to reduced bad cholesterol (LDL-c), total cholesterol and T.G and elevated serum good cholesterol (HDL-c) as increased the activity of lipoprotein lipase, promoted fat oxidation and prevented its accumulation in visceral tissues.
Conclussion
In conclusion, AgNPs (50 mg/kg) intraperitoneal administration could induce hepatotoxicity, oxidative stress, necrosis substantial decrease in cell viability with concomitant increases in DNA damage, because of perturbation hepatocellular membrane, reduction of antioxidant defense, and initiation of down-regulation of Nrf2, PGC-1α and mTFA. On the other hand, cotreatment with LA (100 mg/kg) improved the previous alterations and showed promising hepatoprotective and antioxidant properities. Ag-NPs, Nanosilver particles; LA, α-lipoic acid; GSSG, oxidized glutathione; GSH, reduced glutathione; MDA, malondialdhyde.
Values are means ± standard errors. Means without a common superscript in a column differ significantly (P ≤ 0.05). 3.84 ± 0.36 a 3.20 ± 0.16 a 3.21 ± 0.20 a Ag-NPs, Nanosilver particles; LA, α-lipoic acid. Values are means ± standard errors..Means without a common superscript in a column differ significantly (P ≤ 0.05). Ag-NPs, Nanosilver particles; LA, α-lipoic acid. Values are means ± standard errors. Means without a common superscript in a column differ significantly (P ≤ 0.05). Ag-NPs, Nanosilver particles; LA, α-lipoicacid;TG, Triglycerides; HDL, High density lipoprotein cholesterol; vLDL, very low density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol. Values are means ± standard errors. Means without a common superscript in a column differ significantly (P ≤ 0.05).
( Figure 2 ) Effect of alph-lipolic acid on genes of nano silver treated albino rats Ag-NPs, Nanosilver particles; LA, α-lipoic acid; PGC1-α (Peroxisome proliferator activator receptor gamma-coactivator 1α), mitochondrial transcription factor A (mTFA) and Nrf2 (nuclear factor erythroid 2-related factor) Values are means ± standard errors. Means without a common superscript in a column 
